Sign Up Today and Learn More About Wugen Stock
Invest in or calculate the value of your shares in Wugen or other pre-IPO companies through EquityZen's platform.
Wugen Stock
Wugen is developing off-the-shelf cellular therapies targeting solid tumors and hematologic malignancies
About Wugen Stock
Founded
2018
Headquarters
St Louis, MO, US
Industries
Software, Artificial Intelligence, Data and Analytics
Wugen Press Mentions
Stay in the know about the latest news on Wugen
Missouri Minute: St. Louis-based biotech firm raises $115 million; WashU research team wins grant
missouribusinessalert • Oct 07, 2025
Sanofi Pumps $625M Into Venture Arm to Back Breakthroughs in Early-Stage Startups
medcitynews • Oct 01, 2025
HCW Biologics, a Shareholder of Wugen, Congratulates Wugen on Its Recent Successful Equity Financing
globenewswire • Sep 19, 2025
HCW Biologics congratulates Wugen on equity financing
thefly • Sep 19, 2025
Treeline's $200m Series A extension, and other biofinancings
pharmaphorum • Sep 06, 2025
Wugen Management
Leadership team at Wugen
Chief Operating Officer, Executive Vice President of Research & Development
Ayman Kabakibi
Board Member
Natalie Mount
Join now and verify your accreditation status to gain access to:
- Wugen Current Valuation
- Wugen Stock Price
- Wugen Management
- Available deals in Wugen and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Wugen Cap Table and Funding History by Share Class and Liquidity Preferences
- Wugen Revenue and Financials
- Wugen Highlights
- Wugen Business Model
- Wugen Risk Factors
- Wugen Research Report from SACRA Research
Trading Wugen Stock
How to invest in Wugen stock?
Accredited investors can buy pre-IPO stock in companies like Wugen through EquityZen funds. These investments are made available by existing Wugen shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Wugen stock?
Shareholders can sell their Wugen stock through EquityZen's private company marketplace. EquityZen's network includes over 400K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 49K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."